RESTORATION OF IMMUNE ABNORMALITIES IN DIABETIC BB RATS AFTER PANCREAS TRANSPLANTATION
Authors:
- Toshinori ItoTIToshinori Ito
- Wataru KamiikeWKWataru Kamiike
- Hiroyuki NakaoHNHiroyuki Nakao
- Susumu MakinoSMSusumu Makino
- Masayuki MiyasakaMMMasayuki Miyasaka
- Masumi NozawaMNMasumi Nozawa
- Hikaru MatsudaHMHikaru Matsuda
- 1 June 1996
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (11) , 1629-1636
Abstract
Diabetes-prone (DP) BB rats (RT1(u), RT6.1) spontaneously develop insulin-dependent diabetes mellitus (IDDM) and the disease manifestation resembles that in human IDDM. DP rats are immunodeficient with severe T lymphocytopenia due to the absence of T cells expressing the RT6 differential alloantigen, which have immunoregulatory functions. MHC- and non-MHC-compatible Wistar Furth (WF; RT1(u), RT6.2) pancreases were transplanted into DP rats. WF pancreas grafts were destroyed by IDDM recurrence (insulitis), but not by rejection, with a mean survival time of 65.3 +/- 21.7 days. To prevent the recurrence of IDDM in the grafts, monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 were administered. WF pancreas grafts were indefinitely accepted (>108.0 +/- 26.8 days) in monoclonal antibody-treated DP recipients. The number of T cells was increased and cellular immune responses restored only in the DP rats that had accepted grafts. The increased number of T cells was due to the peripheral appearance of donor-type RT6.2+ T cells, which represented 34.3 +/- 7.0% of total splenic T cells. The cytotoxicity of splenic T cells to WF islet cells was suppressed in the presence of RT6+ T cells in vitro. These findings demonstrated that stable macrochimerism of donor-derived RT6+ T cells could restore the immune responses and prevent the recurrence of IDDM in the DP recipients.Keywords
This publication has 47 references indexed in Scilit:
- Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?Diabetes, 1994
- Insulin prophylaxis in individuals at high risk of type 1 diabetesThe Lancet, 1993
- Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamideDiabetologia, 1991
- Defective inducer T-cell function before the onset of insulin-dependent diabetes mellitusJournal of Autoimmunity, 1991
- HLA antigens and insulin-dependent diabetesNature, 1988
- Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1987
- Immunology of Insulin-Dependent Diabetes MellitusAnnual Review of Immunology, 1985
- Cytotoxic Autoantibodies to Beta Cells in the Serum of Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1980
- Islet Cell Survival Determined by Morphology An Immunocytochemical Study of the Islets of Langerhans in Juvenile Diabetes MellitusDiabetes, 1978
- Insulin-Dependent Diabetes: A Disease of AutoaggressionScience, 1976